Exact Sciences Corporation (EXAS) Drops 5.15% on January 28

Equities Staff |

Exact Sciences Corporation (EXAS) was one of the Russell 2000's biggest losers for Thursday January 28 as the stock slid 5.15% to $6.26, a loss of $-0.34 per share. Starting at an opening price of $6.64 a share, the stock traded between $6.17 and $6.73 over the course of the trading day. Volume was 1.22 million shares over 8,969 trades, against an average daily volume of 3.46 million shares and a total float of 96.34 million.

The losses send Exact Sciences Corporation down to a market cap of $603.08 million. In the last year, Exact Sciences Corporation has traded between $32.85 and $5.77, and its 50-day SMA is currently $8.38 and 200-day SMA is $17.96.

Exact Sciences Corp is a molecular diagnostics company currently focused on the early detection and prevention of colorectal cancer. It has developed a non?invasive, patient friendly screening test called Cologuard(R).

Exact Sciences Corporation is based out of Madison, WI and has some 236 employees. Its CEO is Kevin T. Conroy.

For a complete fundamental analysis analysis of Exact Sciences Corporation, check out Equities.com’s Stock Valuation Analysis report for EXAS. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

CMX Gold & Silver Corp.

CMX Gold & Silver Corp is an exploration stage company. The Company is engaged in the acquisition, exploration and development of silver and copper/gold properties in the USA.

Private Markets

Ozobot by Evollve Inc

Ozobot is a world leader in compact super intelligent robots that entertain and educate through fun interactive gaming.

Santo Diablo Mezcal

Santo Diablo Mezcal has been created to capitalize on a boom sector of the beverage market currently full of many small unmemorable products by producing one sexy, household, easily recognizable…